Medical Xpress·3 min read·medium
Researchers identify proteins fueling rare childhood leukemia, revealing new treatment strategy
✦AI Summary
Researchers at the Indiana University School of Medicine have identified three inflammatory proteins that drive juvenile myelomonocytic leukemia (JMML). The study suggests that existing medications could be repurposed to block this pathway and improve survival rates for pediatric patients.
Why it matters
Repurposing existing drugs for rare, aggressive cancers offers a faster and more accessible path to treatment for high-risk children.
edited by Lisa Lock , reviewed by Andrew Zinin
sciencehealth
Political Bias
Center
LeftLean LCenterLean RRight
Confidence: 90%
The article is a straightforward summary of scientific research findings.
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in